These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

407 related items for PubMed ID: 7970700

  • 21. Preferential activation of Fgf8 by proviral insertion in mammary tumors of Wnt1 transgenic mice.
    Kapoun AM, Shackleford GM.
    Oncogene; 1997 Jun 19; 14(24):2985-9. PubMed ID: 9205106
    [Abstract] [Full Text] [Related]

  • 22. Specific protection against breast cancers by cyclin D1 ablation.
    Yu Q, Geng Y, Sicinski P.
    Nature; 2001 Jun 28; 411(6841):1017-21. PubMed ID: 11429595
    [Abstract] [Full Text] [Related]

  • 23. Mnt-deficient mammary glands exhibit impaired involution and tumors with characteristics of myc overexpression.
    Toyo-oka K, Bowen TJ, Hirotsune S, Li Z, Jain S, Ota S, Escoubet-Lozach L, Garcia-Bassets I, Lozach J, Rosenfeld MG, Glass CK, Eisenman R, Ren B, Hurlin P, Wynshaw-Boris A.
    Cancer Res; 2006 Jun 01; 66(11):5565-73. PubMed ID: 16740691
    [Abstract] [Full Text] [Related]

  • 24. Transgenic oncogene mice. Tumor phenotype predicts genotype.
    Cardiff RD, Sinn E, Muller W, Leder P.
    Am J Pathol; 1991 Sep 01; 139(3):495-501. PubMed ID: 1887859
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. Gene expression analysis of immune-mediated arrest of tumorigenesis in a transgenic mouse model of HER-2/neu-positive basal-like mammary carcinoma.
    Astolfi A, Landuzzi L, Nicoletti G, De Giovanni C, Croci S, Palladini A, Ferrini S, Iezzi M, Musiani P, Cavallo F, Forni G, Nanni P, Lollini PL.
    Am J Pathol; 2005 Apr 01; 166(4):1205-16. PubMed ID: 15793299
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. H-ras induced transformation of mammary epithelium is favoured by increased oncogene expression or by inhibition of mammary regression.
    Andres AC, Bchini O, Schubaur B, Dolder B, LeMeur M, Gerlinger P.
    Oncogene; 1991 May 01; 6(5):771-9. PubMed ID: 2052356
    [Abstract] [Full Text] [Related]

  • 30. Regulation of epidermal growth factor receptor by activated H-ras and V-myc oncogenes in mouse Balb/3T3 cells: possible roles of AP-1.
    Okimoto T, Kohno K, Kuwano M, Gopas J, Kung HF, Ono M.
    Oncogene; 1996 Apr 18; 12(8):1625-33. PubMed ID: 8622882
    [Abstract] [Full Text] [Related]

  • 31. Wnt pathway component LEF1 mediates tumor cell invasion and is expressed in human and murine breast cancers lacking ErbB2 (her-2/neu) overexpression.
    Nguyen A, Rosner A, Milovanovic T, Hope C, Planutis K, Saha B, Chaiwun B, Lin F, Imam SA, Marsh JL, Holcombe RF.
    Int J Oncol; 2005 Oct 18; 27(4):949-56. PubMed ID: 16142310
    [Abstract] [Full Text] [Related]

  • 32. Tumorigenic conversion of primary human esophageal epithelial cells using oncogene combinations in the absence of exogenous Ras.
    Kim SH, Nakagawa H, Navaraj A, Naomoto Y, Klein-Szanto AJ, Rustgi AK, El-Deiry WS.
    Cancer Res; 2006 Nov 01; 66(21):10415-24. PubMed ID: 17079462
    [Abstract] [Full Text] [Related]

  • 33. Analysis of the int-1, int-2, c-myc, and neu oncogenes in human breast carcinomas.
    Meyers SL, O'Brien MT, Smith T, Dudley JP.
    Cancer Res; 1990 Sep 15; 50(18):5911-8. PubMed ID: 1975511
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. Genetic modulation of neu proto-oncogene-induced mammary tumorigenesis.
    Rowse GJ, Ritland SR, Gendler SJ.
    Cancer Res; 1998 Jun 15; 58(12):2675-9. PubMed ID: 9635596
    [Abstract] [Full Text] [Related]

  • 37. Differential effects of p21(WAF1/CIP1) deficiency on MMTV-ras and MMTV-myc mammary tumor properties.
    Bearss DJ, Lee RJ, Troyer DA, Pestell RG, Windle JJ.
    Cancer Res; 2002 Apr 01; 62(7):2077-84. PubMed ID: 11929828
    [Abstract] [Full Text] [Related]

  • 38. Amplification of protooncogenes in surgical specimens of human lung carcinomas.
    Shiraishi M, Noguchi M, Shimosato Y, Sekiya T.
    Cancer Res; 1989 Dec 01; 49(23):6474-9. PubMed ID: 2573414
    [Abstract] [Full Text] [Related]

  • 39. Myc/p53 interactions in transgenic mouse mammary development, tumorigenesis and chromosomal instability.
    McCormack SJ, Weaver Z, Deming S, Natarajan G, Torri J, Johnson MD, Liyanage M, Ried T, Dickson RB.
    Oncogene; 1998 May 28; 16(21):2755-66. PubMed ID: 9652742
    [Abstract] [Full Text] [Related]

  • 40. Difference in the response of neu and ras oncogene-induced rat mammary carcinomas to early and late ovariectomy.
    Wang B, Kennan WS, Yasukawa-Barnes J, Lindstrom MJ, Gould MN.
    Cancer Res; 1992 Aug 01; 52(15):4102-5. PubMed ID: 1353410
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 21.